Mr. Zohar Krivorot reports

CANNARA BIOTECH INC. TO ANNOUNCE FISCAL Q2 2025 FINANCIAL RESULTS ON APRIL 28, 2025

Cannara Biotech Inc. will release its financial results for the second quarter ended Feb. 28, 2025, on Monday, April 28, 2025, at 7 a.m. ET.

Cannara Biotech's chief financial officer, Nicholas Sosiak, will host an earnings webcast on Tuesday, April 29, 2025, at 11 a.m. ET, consisting of prepared remarks followed by a question-and-answer session.

Participants can find the live webcast on the Cannara Biotech website. For interested individuals unable to join, the event will be archived on the company's website.

Investors are encouraged to submit questions in advance to investors@cannara.ca. While live questions will be accepted during the session, priority will be given to those submitted by e-mail.

About Cannara Biotech Inc.

Cannara Biotech is a vertically integrated producer of affordable, premium-grade cannabis and cannabis-derivative products for the Canadian markets. Cannara owns two megafacilities based in Quebec, spanning over 1.65 million square feet and providing the company with 100,000 kilograms of potential annualized cultivation output. Leveraging Quebec's low electricity costs, Cannara's facilities produce premium-grade cannabis products at an affordable price.

We seek Safe Harbor.